ARPP19 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.83419954172359E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.28139999961464E-07 |
Normal-vs-Stage2 |
5.995600E-03 |
Normal-vs-Stage3 |
2.21622720175674E-12 |
Normal-vs-Stage4 |
2.28173036020962E-12 |
Stage1-vs-Stage2 |
8.774800E-01 |
Stage1-vs-Stage3 |
2.032500E-04 |
Stage1-vs-Stage4 |
7.94200000000522E-05 |
Stage2-vs-Stage3 |
6.380000E-02 |
Stage2-vs-Stage4 |
2.702400E-02 |
Stage3-vs-Stage4 |
5.224200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.80959733045938E-11 |
Normal-vs-AfricanAmerican |
8.21089973790379E-10 |
Normal-vs-Asian |
4.873800E-01 |
Caucasian-vs-AfricanAmerican |
9.257800E-02 |
Caucasian-vs-Asian |
3.020000E-01 |
AfricanAmerican-vs-Asian |
7.876000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.0286994306673E-11 |
Normal-vs-Female |
2.69969999688868E-08 |
Male-vs-Female |
3.407400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.101190E-03 |
Normal-vs-Age(41-60Yrs) |
3.83679999993447E-08 |
Normal-vs-Age(61-80Yrs) |
2.69020361542971E-11 |
Normal-vs-Age(81-100Yrs) |
5.33959999993172E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.848800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.442600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.292200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.359400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.115050E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.857600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.157400E-01 |
Normal-vs-Grade 2 |
5.70879999999274E-05 |
Normal-vs-Grade 3 |
2.68585154117318E-12 |
Normal-vs-Grade 4 |
1.62458935193399E-12 |
Grade 1-vs-Grade 2 |
2.878800E-01 |
Grade 1-vs-Grade 3 |
3.500900E-03 |
Grade 1-vs-Grade 4 |
1.51371999999039E-05 |
Grade 2-vs-Grade 3 |
1.756500E-04 |
Grade 2-vs-Grade 4 |
3.69380004361375E-09 |
Grade 3-vs-Grade 4 |
4.057200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.991200E-04 |
Normal-vs-ccB subtype |
1.99119998267605E-09 |
ccA subtype-vs-ccB subtype |
4.058000E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.13219997213798E-09 |
Normal-vs-N1 |
5.969900E-02 |
N0-vs-N1 |
9.461000E-01 |
|
|